Re: A randomized trial of radical radiotherapy for the management of pT1G3 NXM0 transitional cell carcinoma of the bladder. S. J. Harland, H. Kynaston, K. Grigor, D. M. Wallace, C. Beacock, R. Kockelbergh, S. Clawson, T. Barlow, M. K. Parmar and G. O. Griffiths; National Cancer Research Institute Bladder Clinical Studies Group. J Urol 2007; 178: 807-813.

Authors	Donald L Lamm
Journal	The Journal of urology (J Urol) Vol. 179 Issue 4 Pg. 1639-40; author reply 1640-1 (Apr 2008) ISSN: 1527-3792 [Electronic] United States
PMID	18295248 (Publication Type: Comment, Letter)
Topics	Carcinoma, Transitional Cell (pathology, radiotherapy) Humans Neoplasm Staging Randomized Controlled Trials as Topic Urinary Bladder Neoplasms (pathology, radiotherapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!